文献速递糖尿病肥胖与代谢综合征

高胰岛素血症、胰岛素抵抗、肥胖与2型糖尿病血糖异常的因果关系探讨

On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes.
PubMed 文献 · Diabetologia · 2021-07-22

本文为针对Esser等综述的辩论文章,回顾了高胰岛素血症与葡萄糖刺激胰岛素分泌受损在健康、肥胖至糖尿病进展中的相对贡献。结论认为这两种β细胞缺陷并非互斥,均重要但阶段不同。

要点

  • 高胰岛素血症与胰岛素分泌缺陷是不同阶段的β细胞异常,非互斥。
  • 二者在从代谢健康到2型糖尿病的进展中均发挥作用。
  • 需结合人體试验与动物研究数据理解其因果关系。

核心结论

  • β细胞缺陷(高胰岛素血症与葡萄糖刺激胰岛素分泌受损)并非互斥,均重要但出现于不同阶段。

研究设计与样本

  • 本文为辩论性文章,基于人體试验和高度控制的动物研究数据,回应Esser等在Diabetologia的综述。

主要发现

  • 高胰岛素血症和葡萄糖刺激胰岛素分泌受损在健康、肥胖与糖尿病进展中的相对贡献随阶段变化。

临床怎么用

  • 临床需认识高胰岛素血症与胰岛素分泌缺陷在不同疾病阶段的角色,指导评估与干预时机。

局限性

  • 原文未报告具体研究样本量、效应值或统计显著性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hundreds of millions of people are affected by hyperinsulinaemia, insulin resistance, obesity and the dysglycaemia that mark a common progression from metabolic health to type 2 diabetes. Although the relative contribution of these features and the order in which they appear may differ between individuals, the common clustering and seemingly progressive nature of type 2 diabetes aetiology has guided research and clinical practice in this area for decades. At the same time, lively debate around the causal relationships between these features has continued, as new data from human trials and highly controlled animal studies are presented. This 'For debate' article was prompted by the review in Diabetologia by Esser, Utzschneider and Kahn ( https://doi.org/10.1007/s00125-020-05245-x ), with the purpose of reviewing established and emerging data that provide insight into the relative contributions of hyperinsulinaemia and impaired glucose-stimulated insulin secretion in progressive stages between health, obesity and diabetes. It is concluded that these beta cell defects are not mutually exclusive and that they are both important, but at different stages.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Johnson JD. On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes. Diabetologia. 2021. PMID: 34296322. doi:10.1007/s00125-021-05505-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。